Skip to main content
logo
Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.048
+0.034 (3.35%)
Oct 13, 2026, 5:22 PM CET

Diamyd Medical AB Financials Overview

Millions SEK. Fiscal year is Sep - Aug.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Revenue
0.480.480.130.130.550.45
Revenue Growth
266.92%266.92%0%-76.19%20.26%79.45%
Gross Profit
-2.28-2.28-3.71-3.58-3.09-3.95
Operating Income
-257.58-257.58-183.23-147.27-115.85-114.94
Net Income
-255.59-255.59-169.78-151.85-116.07-103.52
Earnings Per Share
-1.76-1.76-1.51-1.60-1.48-1.35
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Net Cash (Debt)
305.43305.43277.19132.37127.53159.67
Net Cash Growth
10.19%10.19%109.41%3.79%-20.13%14.56%
Net Cash Per Share
2.102.102.461.401.632.09
Cash & Investments
305.43305.43277.19132.37127.53159.67

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Operating Cash Flow
-195.31-195.31-169.68-129.18-110.96-93.22
Capital Expenditures
-0.99-0.99-10.05-8.03-11.44-34.65
Free Cash Flow
-196.3-196.3-179.73-137.21-122.4-127.87
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Gross Margin
------
Operating Margin
-53999.37%-53999.37%-140949.23%-113287.69%-21217.22%-25316.30%
Pretax Margin
-53583.44%-53583.44%-130597.69%-116807.69%-21258.79%-22801.10%
Profit Margin
-53583.44%-53583.44%-130597.69%-116807.69%-21258.79%-22801.10%
FCF Margin
-41153.67%-41153.67%-138254.61%-105543.08%-22418.32%-28165.42%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Forward PE
-4.61129.14260.00260.00260.00
PS Ratio
329.46332.7111951.9012595.781538.112470.47